MedPath

A randomised trial of the cost-effectiveness of a program of screening and intensive multifactorial intervention for type 2 diabetes in primary care

Not Applicable
Completed
Conditions
Type 2 diabetes
Nutritional, Metabolic, Endocrine
Non-insulin-dependent diabetes mellitus
Registration Number
ISRCTN86769081
Lead Sponsor
niversity of Cambridge (UK)
Brief Summary

2009 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/19435491 protocol 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23040422 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27583404 results 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29903781 results (added 11/07/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31370851 results (added 05/08/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/32918549/ (added 26/10/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20184
Inclusion Criteria

1. Aged 40 to 69 years
2. Without known diabetes but with a diabetes risk score in the top 30%

Exclusion Criteria

1. Already have diabetes
2. Are pregnant or lactating
3. Have a psychotic illness
4. Have an illness with a prognosis of less than one year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Risk models for mortality and cardiovascular events, specific to people with diabetes, based on age, gender, blood pressure, Body Mass Index (BMI), smoking, previous myocardial infarction, total cholesterol, triglyceride, High Density Lipoprotein (HDL), HbA1c and albuminuria.
Secondary Outcome Measures
NameTimeMethod
o secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath